Subscriptions, Current Issue & Back Issues

Shop Website | Annual Subscriptions | Back Issues |

Tag: thimerosal

The Truth Behind the Vaccine Coverup By Russell L. Blaylock, M.D.

From the excellent Mercola.com website:

I was asked to write a paper on some of the newer mechanisms of vaccine damage to the nervous system, but, in the interim, I came across an incredible document that should blow the lid off the coverup being engineered by the pharmaceutical companies in conjunction with powerful governmental agencies.

It all started when a friend of mine sent me a copy of a letter from Congressman David Weldon (R-Fla.), M.D. to the director of the CDC, Dr Julie L. Gerberding, in which he alludes to a study by a Dr. Thomas Verstraeten, then representing the CDC, on the connection between infant exposure to thimerosal-containing vaccines and neurodevelopmental injury.

In this shocking letter, Weldon refers to Dr. Verstraeten‘s study which looked at the data from the Vaccine Safety Datalink and found a significant correlation between thimerosal exposure via vaccines and several neurodevelopmental disorders including tics, speech and language delays and possibly to ADD.

Weldon questioned the CDC director as to why, following this meeting, Dr. Verstraeten published his results, almost four years later, in the journal Pediatrics to show just the opposite. That is, there was no correlation to any neurodevelopmental problems related to thimerosal exposure in infants. In his letter, Weldon refers to a report of the minutes of this meeting held in Georgia, which exposes some incredible statements by the “experts” making up this study group.

The group‘s purpose was to evaluate and discuss Dr. Verstraeten‘s results and data and make recommendation that would eventually lead to possible alterations in the existing vaccine policy.

Pulling Teeth

I contacted Weldon‘s legislative assistant and he kindly sent me a complete copy of this report. Now, as usual in these cases, the government did not give up this report willingly. It required a Freedom of Information Act lawsuit to pry it loose. Having read the report twice and carefully analyzing it, I can see why they did not want any outsiders to look at it. It is a bombshell, as you shall see.

In this analysis, I will not only describe and discuss this report, but also will frequently quote their words directly and supply the exact page number so others can see for themselves.

The official title of the meeting was the “Scientific Review of Vaccine Safety Datalink Information.” This conference, held on June 7-8, 2000 at the Simpsonwood Retreat Center, Norcross, Ga., assembled 51 scientists and physicians of which five represented vaccine manufacturers (Smith Kline Beecham, Merck, Wyeth, North American Vaccine and Aventis Pasteur).

During this conference, these scientists focused on the study of the Datalink material, whose main author was Dr. Thomas Verstraesten who identified himself as working at the National Immunization Program of the CDC.

(It was discovered by Congressman Weldon that Dr. Verstraeten left the CDC shortly after this conference to work for GlaxoSmithKline in Belgium which manufacturers vaccines, a recurring pattern that has been given the name a “revolving door.” It is also interesting to note that GlaxoSmithKline was involved in several lawsuits over complications secondary to their vaccines.)

To start off the meeting Dr. Roger Bernier, Associate Director for Science in the National Immunization Program (CDC), related some pertinent history. He stated that congressional action in 1977 required that the FDA review mercury being used in drugs and biologics (vaccines). In meeting this order, the FDA called for information from the manufacturers of vaccines and drugs. He notes that a group of European regulators and manufacturers met on April 1999 and noted the situation but made no recommendations of changes.

In other words, it was all for show.

The Lid Blown Off

At this point, Dr. Bernier made an incredible statement (page 12). He said, “In the United States, there was a growing recognition that cumulative exposure may exceed some of the guidelines.” By guidelines, he is referring to those for mercury exposure safety levels set by several regulatory agencies. The three guidelines were set by the Agency for Toxic Substances and Disease Registry (ATSDR), FDA and EPA. The most consistently violated safety guideline was that set by EPA. He further explains that he is referring to children being exposed to thimerosal in vaccines.

Based on this realization that they were violating safety guidelines he says, this then “resulted in a joint statement of the Public Health Service (PHS) and the American Academy of Pediatrics (AAP) in July of last year (1999), which stated that as a long term goal, it was desirable to remove mercury from vaccines because it was a potentially preventable source of exposure.” (Page 12)

As an aside, one has to wonder, where was the Public Health Service and American Academy of Pediatrics during all the years of mercury use in vaccines and why didn‘t they know that:

  • They were exceeding regulatory safety levels.
  • Why weren‘t they aware of the extensive literature showing deleterious effects on the developing nervous system of babies?

As we shall see even these “experts” seem to be cloudy on the mercury literature.

An Earlier Meeting

Dr. Bernier notes that in August 1999, a public workshop was held in Bethesda, Md., at the Lister Auditorium by the National Vaccine Advisory Group and the Interagency Working Group on Vaccines to consider thimerosal risk in vaccine use. And based on what was discussed in that conference, thimerosal was removed from the hepatitis B vaccine (HepB).

It is interesting to note that the media took very little interest in what was learned at that meeting and it may have been a secret meeting as well. As we shall see, there is a reason why they struggle to keep the contents of all these meetings secret from the public.

Bernier then notes, on page 13, that in October 1999, the Advisory Committee on Immunization Practices (ACIP) “looked this situation over again and did not express a preference for any of the vaccines that were thimerosal free.” In this discussion, he further notes the ACIP concluded that the thimerosal-containing vaccines could be used but the “long-term goal is to try to remove thimerosal as soon as possible.”

Now, we need to stop and think about what has transpired here. We have an important group here — the ACIP — that essentially plays a role in vaccine policy that affects tens of millions of children every year. And, we have evidence from the thimerosal meeting in 1999 that the potential for serious injury to the infant‘s brain is so serious that a recommendation for removal becomes policy.

In addition, they are all fully aware that tiny babies are receiving mercury doses that exceed even EPA safety limits, yet all they can say is that we must “try to remove thimerosal as soon as possible?” Do they not worry about the tens of millions of babies that will continue receiving thimerosal-containing vaccines until they can get around to stopping the use of thimerosal?

The Obvious Solution

It should also be noted that it is a misnomer to say “removal of thimerosal” since they are not removing anything. They just plan to stop adding it to future vaccines once they use up existing stocks, which entails millions of doses. And, incredibly, the government allows them to do it.

Even more incredibly, the American Academy of Pediatrics and the American Academy of Family Practice similarly endorse this insane policy. In fact, they specifically state that children should continue to receive the thimerosal-containing vaccines until new thimerosal-free vaccines can be manufactured at the will of the manufacturers. Are they afraid that there will be a sudden diphtheria epidemic in America or tetanus epidemic?

The most obvious solution was to use only single-dose vials, which requires no preservative. So why don‘t they use them?

Oh, they exclaim, it would add to the cost of the vaccine. Of course, we are only talking about a few dollars per vaccine at most, certainly worth the health of your child‘s brain and future. They could use some of the hundreds of millions of dollars they waste on vaccine promotion every year to cover these costs for the poor. Then, that would cut into some “fat cat‘s” budget and we can‘t have that.

It was disclosed that thimerosal was in all influenza vaccines, DPT (and most DtaP) vaccines and all HepB vaccines.

As they begin to concentrate on the problem at hand we first begin to learn that the greatest problem with the meeting is that, they know virtually nothing about what they are doing. On page 15, for example, they admit that there is very little pharmacokinetic data on ethylmercury, the form of mercury in thimerosal. In fact, they say there is no data on excretion and the data on toxicity is sparse. Yet it is recognized to cause hypersensitivity, neurological problems and even death, and it is known to easily pass the blood-brain and placental barriers.

For the rest of the article, go here:

Flashback: Merck’s Coverup of High Levels of Mercury in Vaccines Sends Them Into the Spotlight Again

Mercola.com February 23 2005 Mercury Vaccine

A memo from Merck & Co. showed that, nearly a decade before the first public disclosure, senior executives were concerned that infants were getting an elevated dose of mercury in vaccinations containing a widely used sterilizing agent.

Around the same time this memo was being prepared, U.S. authorities were also aggressively pursuing the expansion of their vaccination schedule to include an additional five shots for children in their first six months. The danger that these shots pose lies in its deadly ingredient: thimerosal, an antibacterial compound that is composed of nearly 50 percent ethyl mercury, a neurotoxin.

What the Memo Said

The memo, which was written back in 1991, disclosed that 6-month-old children who received their shots on schedule would be receiving a mercury dose nearly 87 times higher than guidelines for the maximum daily consumption of mercury from fish. In addition, it included the following recommendation: whenever possible, particularly among use in infants and young children, vaccines with mercury should be eliminated.

The memo also stated that unlike regulators in Sweden and some other countries, the U.S. Food and Drug Administration does not share the same concern regarding thimerosal.

Merck Tries to Keep its Head Above Vioxx Lawsuits and Vaccine Claims

The Vaccine Injury Compensation Program has received over 4,200 vaccine-related complaints by parents reporting their children experienced side effects such as autism or other neurodevelopmental disorders from the mercury in vaccines.

Meanwhile, Merck has been faced with fighting off legal battles over Vioxx, the popular painkiller that has caused hundreds of lawsuits after being linked to cardiac problems and Merck covering up the risks.

Undisclosed company documents show that the drug maker was in the process of beginning a major cardiovascular study of the drug in 2002, and suddenly dropped the project just before it was set to start. The trial was scheduled to produce data by March 2004 but may have provided answers about Vioxx’s risks even earlier if patients had shown ill effects.

It was not until September 2004 that Merck put a stop to a separate study when patients in that trial experienced heart attacks and strokes at twice the rate of those receiving a placebo. At the same time, Merck withdrew Vioxx from the market.

Small Steps Made to Address the Mercury in Vaccines

In recent years thimerosal had been taken out of pediatric vaccines in what health officials described as a precautionary measure but it still remains in most doses of the flu vaccine.

Also, government officials like Governor Arnold Schwarzenegger became proactive in the vaccine dilemma in September when he signed legislation that banned vaccines containing more than traces of thimerosal from being given to both babies and pregnant woman.

Related:

Merck Canceled an Early Study of Vioxx

Interview with a whistleblower who worked for Big Pharma